Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schattenberg
L Stump

Showing results (321-330 of 392) with videos related to

Pageof 40
Sort By:
Alimentary Pharmacology & Therapeutics|December 6, 2021
A sustainable development goal framework to guide multisectoral action on NAFLD through a societal approachJeffrey V Lazarus, Henry E Mark, Massimo Colombo, et al.
JHEP Reports : Innovation in Hepatology|July 15, 2024
Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patientsJulia Dietz, Christiana Graf, Christoph P Berg, et al.
Molecular Pharmacology|November 23, 2005
Block of peripheral nerve sodium channels selectively inhibits features of neuropathic pain in ratsRichard M Brochu, Ivy E Dick, Jason W Tarpley, et al.
Plos One|February 29, 2024
Machine learning approaches to enhance diagnosis and staging of patients with MASLD using routinely available clinical informationMatthew McTeer, Douglas Applegate, Peter Mesenbrink, et al.
Bioorganic & Medicinal Chemistry Letters|September 5, 2006
Potent antagonists of the Kv1.5 potassium channel: synthesis and evaluation of analogous N,N-diisopropyl-2-(pyridine-3-yl)acetamidesKausik K Nanda, M Brad Nolt, Matthew J Cato, et al.
Journal of Medicinal Chemistry|January 26, 2007
Identification and characterization of 4-methylbenzyl 4-[(pyrimidin-2-ylamino)methyl]piperidine-1-carboxylate, an orally bioavailable, brain penetrant NR2B selective N-methyl-D-aspartate receptor antagonistNigel J Liverton, Rodney A Bednar, Bohumil Bednar, et al.
JHEP Reports : Innovation in Hepatology|January 16, 2023
Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practiceJeffrey V Lazarus, Laurent Castera, Henry E Mark, et al.
Chinese Medical Journal|February 27, 2023
Hepatocyte apoptosis fragment product cytokeratin-18 M30 level and non-alcoholic steatohepatitis risk diagnosis: an international registry studyHuai Zhang, Rafael S Rios, Jerome Boursier, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 11, 2025
Incidence of Hepatocellular Carcinoma in Metabolic Dysfunction-associated Steatotic Liver Disease: A Reconstructed Individual Patient Data Meta-analysisRyan Yanzhe Lim, Faith Xin Ning Tan, Glenn Jun Kit Ho, et al.
Journal of Viral Hepatitis|May 13, 2020
Resistance-associated substitutions in patients with chronic hepatitis C virus genotype 4 infectionJulia Dietz, Olga V Kalinina, Johannes Vermehren, et al.
Pageof 40

Showing results (321-330 of 392) with videos related to

Sort By:
Pageof 40
Alimentary Pharmacology & Therapeutics|December 6, 2021
A sustainable development goal framework to guide multisectoral action on NAFLD through a societal approachJeffrey V Lazarus, Henry E Mark, Massimo Colombo, et al.
JHEP Reports : Innovation in Hepatology|July 15, 2024
Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patientsJulia Dietz, Christiana Graf, Christoph P Berg, et al.
Molecular Pharmacology|November 23, 2005
Block of peripheral nerve sodium channels selectively inhibits features of neuropathic pain in ratsRichard M Brochu, Ivy E Dick, Jason W Tarpley, et al.
Plos One|February 29, 2024
Machine learning approaches to enhance diagnosis and staging of patients with MASLD using routinely available clinical informationMatthew McTeer, Douglas Applegate, Peter Mesenbrink, et al.
Bioorganic & Medicinal Chemistry Letters|September 5, 2006
Potent antagonists of the Kv1.5 potassium channel: synthesis and evaluation of analogous N,N-diisopropyl-2-(pyridine-3-yl)acetamidesKausik K Nanda, M Brad Nolt, Matthew J Cato, et al.
Journal of Medicinal Chemistry|January 26, 2007
Identification and characterization of 4-methylbenzyl 4-[(pyrimidin-2-ylamino)methyl]piperidine-1-carboxylate, an orally bioavailable, brain penetrant NR2B selective N-methyl-D-aspartate receptor antagonistNigel J Liverton, Rodney A Bednar, Bohumil Bednar, et al.
JHEP Reports : Innovation in Hepatology|January 16, 2023
Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practiceJeffrey V Lazarus, Laurent Castera, Henry E Mark, et al.
Chinese Medical Journal|February 27, 2023
Hepatocyte apoptosis fragment product cytokeratin-18 M30 level and non-alcoholic steatohepatitis risk diagnosis: an international registry studyHuai Zhang, Rafael S Rios, Jerome Boursier, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 11, 2025
Incidence of Hepatocellular Carcinoma in Metabolic Dysfunction-associated Steatotic Liver Disease: A Reconstructed Individual Patient Data Meta-analysisRyan Yanzhe Lim, Faith Xin Ning Tan, Glenn Jun Kit Ho, et al.
Journal of Viral Hepatitis|May 13, 2020
Resistance-associated substitutions in patients with chronic hepatitis C virus genotype 4 infectionJulia Dietz, Olga V Kalinina, Johannes Vermehren, et al.
Pageof 40